After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
TERN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Terns Pharmaceuticals Inc is $743.84M. A total of 0.9 million shares were traded on the day, compared to an average of 1.14M shares.
In the most recent transaction, Kuriakose Emil sold 944 shares of TERN for 7.85 per share on Oct 01 ’25. After the transaction, the Chief Medical Officer now owns 51,520 company shares. In a previous transaction on Jul 01 ’25, Kuriakose Emil sold 853 shares at 4.27 per share. TERN shares that Chief Medical Officer owns now total 52,464.
Among the insiders who bought shares, Gengos Andrew acquired of 10,000 shares on Jun 27 ’25 at a per-share price of $3.93. This resulted in the Chief Financial Officer holding 25,000 shares of TERN after the transaction. In another insider transaction, Burroughs Amy L. bought 23,314 shares at $3.87 per share on Jun 25 ’25. Company shares held by the Chief Executive Officer now total 47,083.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, TERN has a high of $8.78 and a low of $1.87.
As of this writing, TERN has an earnings estimate of -$0.3 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.27 per share and a lower estimate of -$0.35. The company reported an EPS of -$0.28 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TERN’s latest balance sheet shows that the firm has $165.98M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $6.82M in liabilities at the time. Its Book Value Per Share was $3.49, while its Total Shareholder’s Equity was $160.30M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
